Ketamine
Ketalar, Spravato (ketamine) is a small molecule pharmaceutical. Ketamine was first approved as Ketalar on 1982-01-01. It is used to treat burns and pain in the USA. It has been approved in Europe to treat depressive disorder. The pharmaceutical is active against glutamate receptor ionotropic, NMDA 2C, glutamate receptor ionotropic, NMDA 2A, glutamate receptor ionotropic, NMDA 2D, and glutamate receptor ionotropic, NMDA 2B.
| Trade Name | Spravato |
|---|---|
| Common Name | Ketamine |
| Indication | burns, depressive disorder, pain |
| Drug Class | Nmda receptor antagonists; General anesthetics; Dissociative hallucinogens; Analgesics; Antidepressants |
